| Financial Year |
March 31 2023 |
| Monetary Funds |
341,697,987.61 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,540,000.00 |
| Accounts Receivable |
228,336,017.76 |
| Advances to Suppliers |
42,412,095.92 |
| Other Receivables |
69,531,676.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
93,445,750.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
15,746,050.38 |
| Other Current Assets |
48,382,828.56 |
| Total Current Assets |
913,128,883.12 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
34,304,884.48 |
| Long-term Equity Investment |
238,186,715.23 |
| Investment Properties |
4,501,854.81 |
| Fixed Assetes |
149,530,002.46 |
| Under-construction Projects |
263,251,524.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
236,207,214.27 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,025,005.00 |
| Deferred Income Tax Assets |
7,824,682.47 |
| Other Non-Current Assets |
560,869,600.74 |
| Sub-Total of Non-Current Assets |
1,540,026,027.30 |
| Total Assets |
2,453,154,910.42 |
| Short-Term Loans |
103,010,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
151,336,948.73 |
| Accounts Payable |
298,871,153.15 |
| Accounts Received In Advance |
28,571.43 |
| Employee Compensation Payable |
7,484,482.38 |
| Taxes Payable |
8,399,516.93 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
343,903,929.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,616,543.60 |
| Other Current Liabilities |
80,769,115.07 |
| Sub-Total of Current Liabilities |
1,038,314,297.41 |
| Long-term Loans |
104,270,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
32,085,860.03 |
| Sub-Total of Non-Current Liabilities |
153,064,329.27 |
| Total Liabilities |
1,191,378,626.68 |
| Paid-In Capital(Or Share Stock) |
642,857,142.00 |
| Capital Surplus |
393,643,984.27 |
| Surplus Reserve |
47,672,869.79 |
| LESS:Treasury Stock |
43,004,972.00 |
| Undistributed Profits |
-9,494,500.28 |
| Minority Stockholder's Interest |
230,108,051.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,031,668,231.85 |
| Owner's Equity（Stockholder's Equity） |
1,261,776,283.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,453,154,910.42 |
